MassChallenge

Aseptuva is an early-stage MedTech startup located in Technopark Winterthur, dedicated to addressing Healthcare-Associated Infections (HAI) that arise from catheter use in healthcare facilities. Catheters, essential for delivering medications, are often contaminated with pathogens, leading to severe complications such as pneumonia and bloodstream infections, which result in significant mortality and substantial healthcare costs. To combat this issue, Aseptuva is developing innovative medical devices designed for in-situ disinfection of various catheters, aiming to prevent infections before they occur. The company’s technology offers a robust automated system that assists medical staff, ultimately helping hospitals reduce the incidence of infections and save lives. Aseptuva aspires to establish a new standard in critical care, positively influencing millions of patients worldwide.

HeroSupport is a medical device manufacturing company based in Veyrier, Geneva, established in 2019. The company specializes in creating personalized solutions that transform imaging and treatment tables into medical immobilization devices designed to enhance patient comfort during clinical procedures. By providing tailored support, these devices allow patients to receive prone breast radiotherapy without the need to adapt to the standard table setup. This innovation not only improves patient comfort but also aims to enhance the effectiveness and cost efficiency of cancer treatment for healthcare providers.

Selmod, based in Basel, Switzerland, specializes in developing innovative therapies aimed at treating life-threatening, multi-drug resistant infections. The company focuses on discovering and advancing small molecules and peptides that target new mechanisms of action, addressing the urgent need for effective treatments in hospital settings where first-line therapies have failed. Selmod aims to provide second-line and last-resort options through a disruptive approach that incorporates dual modes of action to overcome resistance mechanisms. The company's lead candidates, SLM500, SLM100, and SLM300, have shown promise in preclinical studies, with market projections indicating a total available market exceeding $9 billion. With an experienced leadership team skilled in advancing clinical candidates for major pharmaceutical companies, Selmod plans to utilize funding to advance three IND-enabling candidates and six lead-optimized candidates into proof-of-concept stages.

Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company is known for its flagship product, munevo DRIVE, a Smartglass application that enables users to control electric wheelchairs through head movements, translating these movements into digital signals for hands-free operation. This technology provides users with greater independence and the ability to navigate both indoor and outdoor environments. In addition to the Smartglass application, Munevo also offers various adaptors and accessories to complement its solutions, further supporting the mobility needs of its users.

Eaternity AG is a software management company based in Zurich, Switzerland, that specializes in the restaurant industry. Founded in 2014 by Judith Ellens and Manuel Klarmann at ETH Zurich, Eaternity provides a platform that offers a real-time calculation engine for addressing allergen and nutrition declarations, as well as assessing the carbon footprint of meals and restaurants. The company's solutions enable restaurant owners to gain valuable insights into their supply chain, facilitating informed decision-making. Eaternity also aims to support organizations globally in calculating the environmental impact of their food products, striving for a sustainable food system within the planet's ecological boundaries. Through its Eaternity Score, the company transparently communicates the environmental effects of various food products, serving both consumers and decision-makers.

VAY is a computer vision company that specializes in digitizing human movements using simple camera technology. Founded in 2019 and based in Zurich, Switzerland, VAY's platform leverages artificial intelligence to enable precise perception and prediction of human motion. This innovative approach provides businesses with the ability to measure, analyze, and customize their products, enhancing outcomes across various applications, including health, sports, and gaming. VAY distinguishes itself with a system and hardware agnostic methodology, allowing for seamless integration into existing workflows. Their technology aims to create smarter, more interactive experiences by utilizing real-life data and feedback.

Plastogaz is a Swiss company based in Lausanne that specializes in producing natural gas from waste resources, specifically synthetic plastic waste. Founded in 2019, Plastogaz employs a patented catalyst technology to convert mixed plastics into grid-compatible methane and naphtha, which can be utilized as fuel or for creating new synthetic materials. This innovative approach not only facilitates the recycling of plastic waste but also aims to reduce greenhouse gas emissions associated with plastic disposal, contributing to a more sustainable environment.

NaturLoop is a Swiss-based cleantech and material science company focused on sustainable development through the production of natural biocomposites. The company specializes in manufacturing coconut-based fiberboard made from agricultural and agroforestry waste, utilizing a low-tech process that promotes circular economy practices. NaturLoop's innovative approach not only addresses environmental concerns but also aims to provide affordable and accessible sustainable materials for the construction sector. By leveraging existing wood panel infrastructure, NaturLoop offers a versatile and eco-friendly alternative to expensive imported building materials. Additionally, the company emphasizes community involvement, integrating local rural communities into its value chain while developing commercially viable products that help mitigate the depletion of natural resources.

Authena is a traceability solution provider headquartered in Zug, Switzerland, specializing in enhancing transparency across the supply chain through the integration of IoT devices, blockchain, and AI technologies. Its platform offers real-time, unit-level tracking and environmental condition monitoring, enabling industries such as Pharmaceuticals, Luxury, and Food and Beverage to safeguard brand reputation and consumer trust. Authena's notable products, Authena SHIELD™ and Authena L1VE, not only comply with regulatory standards but also foster consumer confidence through transparency and authenticity. The company is recognized for its commitment to sustainability and is the only traceability solution provider incorporated into NEOM's Oxagon accelerator, positioning itself as a leader in promoting a greener future. By protecting product identity against counterfeiting, diversion, and fraud, Authena helps brands achieve full visibility, improve financial performance, and enhance direct-to-consumer sales.

Oxyle AG is a Swiss company based in Zurich that specializes in wastewater treatment aimed at removing persistent and toxic micropollutants from water sources. Established in 2020, the company has developed a novel technology that effectively degrades hazardous substances, including pharmaceuticals, personal-care products, endocrine-disrupting chemicals, pesticides, and industrial chemicals. Oxyle serves a diverse clientele, including the pharmaceutical, biotech, chemical, food and beverage sectors, research laboratories, hospitals, and wastewater treatment facilities. Its innovative approach not only helps clients comply with regulatory standards but also offers a sustainable alternative to wastewater incineration, thereby contributing to reduced CO2 emissions.

Munevo GmbH, founded in 2011 and based in Nuremberg, Germany, specializes in developing innovative technology to enhance mobility for individuals with disabilities. The company is known for its flagship product, munevo DRIVE, a Smartglass application that enables users to control electric wheelchairs through head movements, translating these movements into digital signals for hands-free operation. This technology provides users with greater independence and the ability to navigate both indoor and outdoor environments. In addition to the Smartglass application, Munevo also offers various adaptors and accessories to complement its solutions, further supporting the mobility needs of its users.

Lyfegen is an independent provider of drug access, pricing, and rebate management solutions, with operations in Basel, Switzerland, and Boston, USA. The company specializes in helping healthcare payers and pharmaceutical companies establish appropriate pricing agreements for medications while efficiently managing drug rebates. Its platform is designed for the healthcare industry, assisting health insurance providers, pharmaceutical companies, MedTech firms, and hospitals worldwide in collecting, analyzing, and reconciling diverse healthcare data. This technology facilitates the automation of value-based healthcare contracting, ultimately aiming to enhance access to treatments, improve patient health outcomes, and increase affordability.

Readily3D is a Swiss company based in Lausanne, specializing in volumetric 3D printing solutions. Founded in 2020 as a spin-off from the École Polytechnique Fédérale de Lausanne (EPFL), the company has developed innovative printers capable of producing complex, patient-specific devices in under 30 seconds using tomography. Their technology utilizes a liquid photosensitive polymer, which is cured through dynamic light patterns from multiple angles, allowing for the creation of tailored orthoses for patients with hearing loss and surgical models for medical professionals. This approach not only enhances patient care but also streamlines surgical planning, positioning Readily3D as a leader in the advancement of personalized medical devices.

Synthara AG, a Swiss semiconductor startup founded in 2019 and based in Zurich, specializes in designing advanced smart sensors for industrial Internet of Things (IoT) applications and other energy-sensitive uses. The company focuses on developing energy-efficient computational AI chips tailored for various applications, including wearables, health monitoring, augmented reality/virtual reality, and aerospace technologies. Its flagship product, ComputeRAM, serves as a drop-in replacement for traditional SRAM, enabling complex calculations to be performed directly in memory. This innovation significantly reduces CPU workload, enhances system performance, and improves efficiency, particularly for AI applications. Synthara's technology is processor-type agnostic, compatible with architectures such as RISC-V, ARM, and x86, allowing seamless integration into existing microcontroller platforms. By empowering chipmakers and device manufacturers, Synthara aims to lower costs, accelerate time to market, and foster new avenues for innovation in the semiconductor industry.

Amphasys is a technology company specializing in chip-based single-cell analysis technology that aims to simplify and expedite complex cell analyses, making them accessible at the point of use rather than solely in advanced laboratories. Founded in 2012 as a spin-off from Axetris AG, Amphasys developed its core technology in 2004 in collaboration with the Swiss Federal Institute of Technology Lausanne. Through extensive research across various cell types, it has demonstrated versatility for applications such as pollen and milk analysis. The technology streamlines processes by eliminating the need for time-consuming sample preparations, such as cell labeling, and reduces reliance on costly laboratory infrastructure. This enables clients to perform label-free analyses of single-cell characteristics, including cell size, morphology, viability, and differentiation. Amphasys has received recognition for its innovation, including the prestigious Swiss startup prize from the W.A. de Vigier Foundation in 2013.

Exomotion SA, founded in 2018 and based in Plan-les-Ouates, Switzerland, specializes in the development of innovative personal mobility devices. The company's focus is on robotics-based transporter systems that facilitate omnidirectional movement. Exomotion's electronic movement devices integrate advanced electrical boards with motion sensors and a unique wheeled mechanism, allowing for seamless movement in any direction and immediate rotation. This design aims to enhance user experience by rethinking e-mobility, prioritizing both omnidirectionality and safety in its solutions.

Smeetz SA is an online booking platform based in Lausanne, Switzerland, that specializes in the leisure and entertainment industry. Founded in 2016, the company offers a comprehensive suite of solutions designed to streamline event organization and promotion. Its platform incorporates AI-powered tools for sales, marketing, reservation management, ticket booking, and distribution. Smeetz employs dynamic pricing strategies and data analytics to help venues optimize revenue and enhance operational efficiency. The platform also includes features such as a booking widget, cross-channel sales, access control, payment methods, and customizable ticket solutions. By unifying commerce and embedding financial tools, Smeetz aims to transform the customer experience in the leisure sector, enabling businesses to thrive in a competitive environment.

Hi-D Imaging AG, founded in 2019 and based in Winterthur, Switzerland, specializes in a SaaS-based pre-operational planning platform tailored for cardiac procedures, particularly trans-catheter aortic valve implantation. The platform assesses the hemodynamics of patient-specific anatomies, allowing physicians to analyze blood flow patterns and perform in-vitro fluid dynamic analyses. This technology enables the selection of the optimal size and shape of heart valves, facilitating personalized solutions for patients with aortic stenosis before cardiac surgery. By streamlining pre-operational planning and enhancing data-driven decision-making, Hi-D Imaging aims to improve outcomes for patients with cardiovascular diseases while reducing the need for unnecessary medical imaging examinations. The company's AI-based cardiac image processing technology further supports medical professionals by producing detailed images of cardiac structures, thereby decreasing planning times and addressing the limitations of traditional medical scans.

Automation Hero, Inc. specializes in developing artificial intelligence-driven applications to automate sales processes and enhance business efficiency. The company offers a range of tools, including Viz Studio, which enables users to visualize and optimize complex processes; Hero_Go, a screen automation recorder for data extraction and input; and Flow Studio, designed for developers to create tailored solutions. Additionally, Automation Hero provides AI Studio, which addresses limitations in traditional robotic process automation, and domain-intelligent optical character recognition (OCR) technology that digitizes various document types. The company's application, Robin, assists in generating new accounts and leads while streamlining meeting scheduling. Catering to diverse industries such as insurance, banking, technology, retail, manufacturing, telecommunications, and media, Automation Hero aims to improve operational efficiency and reduce repetitive tasks. Founded in 2017 and headquartered in San Francisco, California, the company also has offices in Berlin and Halle, Germany. Formerly known as SalesHero, Inc., it rebranded as Automation Hero, Inc. in March 2019.

Enterprise Bot GmbH is a company that specializes in developing artificial intelligence-driven chatbots aimed at automating customer interactions for enterprises. Founded in 2017 and headquartered in Zug, Switzerland, with an additional office in Bengaluru, India, the company offers a range of products, including chatbots for sales and customer service, email triage bots, and scheduling assistants. Its solutions are particularly beneficial for financial institutions and insurance companies, providing a multi-platform messenger that addresses various customer needs and queries. By implementing these chatbots, enterprises can significantly reduce operational costs and customer wait times, enhancing the overall customer experience.

PXL Vision AG, founded in 2017 and headquartered in Zurich, Switzerland, specializes in the design and development of identity verification and customer onboarding software solutions. Its flagship product, Daego, employs advanced computer vision and machine learning technologies to create trusted digital identities. This cross-platform solution is tailored to meet the needs of various industries, including insurance, fintech, and healthcare, by automating the verification of identity documents and performing facial biometric checks to ensure that users are legitimate and the rightful owners of their documents. By facilitating secure and efficient customer onboarding, PXL Vision aims to enhance conversion rates, reduce costs associated with compliance, and mitigate identity fraud. With research and development centers in Novi Sad, Serbia, and Yerevan, Armenia, PXL Vision is dedicated to establishing a foundation of trust in digital interactions through unbiased and verifiable identities.

CellSpring is a biotechnology company based in Zurich, Switzerland, focused on enhancing cell-based in vitro studies through innovative technology. Its flagship platform, 3D Bloom, allows for the rapid creation of biomimetic microtissues that are independent of cell type. This platform significantly improves upon traditional 3D cell culture methods by offering faster fabrication, greater reliability, and enhanced versatility. The microtissues developed using 3D Bloom are designed to serve various biological functions, including aiding clinicians in the early diagnosis of cancer. Through its advancements, CellSpring aims to facilitate fundamental improvements in the field of biotechnology and medical research.

Planted Foods AG, founded in 2019 and based in Zürich, Switzerland, specializes in the development of plant-based meat products. The company's offerings include planted chicken and BBQ planted chicken, which are crafted using pea protein, pea fiber, sunflower oil, and water to replicate the taste, texture, and mouthfeel of traditional animal meat. By employing advanced technology, Planted Foods transforms these natural ingredients into nutritious, high-protein alternatives that appeal to consumers seeking plant-based options. Additionally, the company operates an e-commerce platform to facilitate the sale of its products directly to customers.

Artiria Medical SA develops innovative micro-actuated devices aimed at treating vascular diseases, particularly in the brain. Founded in 2019 and based in Lausanne, Switzerland, the company focuses on enhancing the precision and control of surgical procedures involving catheters and guidewires. Its technology facilitates micromotion within brain arteries, thereby improving navigation during stroke treatments. By enabling surgeons to perform these complex procedures with greater accuracy, Artiria Medical contributes to better patient outcomes and the potential to save lives.

Dronistics, based in Lausanne, Switzerland, specializes in developing a personal drone delivery system designed for last-centimeter delivery to hard-to-reach locations. The company's drones operate autonomously, utilizing GPS technology and a web application that can be accessed from various devices, including smartphones, tablets, and laptops. Each delivery is facilitated through a 4G internet connection, ensuring seamless control and communication. Dronistics emphasizes safety in its operations, incorporating multiple safety checks to protect individuals during the flight and delivery process. This innovative approach enables logistics and online retail companies to effectively address delivery challenges in remote areas.

Terapet SA, founded in 2019 in Geneva, Switzerland, specializes in proton therapy, an advanced form of radiotherapy for cancer treatment. Established by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals, the company aims to provide precise tumor targeting while minimizing damage to adjacent healthy tissues. Terapet's innovative technology allows for a reduced radiation dose to surrounding healthy cells by administering high doses of protons that halt at specific depths within the patient. This capability enables medical professionals to monitor the proton dose in real-time and in three dimensions, making cancer treatment more effective and potentially more cost-efficient. The company has successfully demonstrated the feasibility of its concept and is in the process of developing an initial version for market launch.

Logmind Ltd is a company based in Lausanne, Switzerland, that specializes in developing an AI-accelerated data analytics platform focused on unstructured log data. Founded in 2018, Logmind’s platform provides visibility and automated insights, enabling organizations to effectively analyze the vast amounts of log data generated by complex IT infrastructures. The platform is designed to assist IT operations and DevOps teams by automatically detecting application issues, thereby helping clients maintain bug-free applications and proactively avoid costly incidents. Key features include real-time error detection, visual dashboards, notifications, and structured insights that transform unorganized datasets into actionable operational intelligence.

CrystalsFirst GmbH specializes in protein crystal stabilization techniques to enhance drug candidate screening, primarily serving pharmaceutical companies. Founded in 2018 and based in Marburg, Germany, the company offers innovative solutions such as SmartSoak technology for screening small molecule arrays, SmartLib for fragment-based drug discovery, and SmartRefine for automated crystallographic data refinement. Their MAGNET platform represents a significant advancement in drug discovery, integrating high-performance structural biology with generative AI and machine learning to identify novel molecules and druggable binding sites. By employing a "crystal structure first" approach, CrystalsFirst facilitates rational drug design and provides valuable insights into target interactions. The company's methodologies enable rapid access to diverse chemical scaffolds, thereby accelerating the discovery of effective therapeutic compounds and enhancing the overall efficiency of the drug development process.

Plair SA specializes in the development and manufacturing of advanced systems for monitoring environmental conditions, particularly focusing on airborne particles. Founded in 2014 and based in Geneva, Switzerland, the company offers a range of innovative instruments, including the Particle Analyzer PA-300, which provides real-time detection, identification, and classification of fine particles in the air. This device can differentiate various entities such as pollen species, organic particles like fungal spores, and pollutants including polycyclic aromatic hydrocarbons. Additionally, Plair SA's Rapid-E and Rapid-C instruments utilize cutting-edge technologies like laser-induced fluorescence and light scattering for comprehensive analysis of aerosol particles. The company's solutions cater to applications in airborne allergen monitoring, air quality assessment, and bioaerosol analysis, enabling a deeper understanding of atmospheric aerosol concentrations. Plair SA is a spin-off from the University of Geneva, reflecting its strong academic foundation.

Regenosca SA is a Swiss company based in Lausanne that specializes in the development and commercialization of medical implants designed for bladder reconstruction. Founded in 2019, the company offers sterile, off-the-shelf implants that serve as alternatives to autologous tissue substitutes for soft tissue repair. These innovative biomaterials aim to enhance bladder preservation and minimize scarring, ultimately improving patients' quality of life. By focusing on easy-to-use medical devices, Regenosca is committed to advancing surgical practices and patient outcomes in bladder-related procedures.

Clemedi AG develops innovative diagnostic workflows for infectious diseases, focusing on in vitro diagnostic tests that leverage next-generation sequencing and machine learning technologies. Established in 2018 and headquartered in Schlieren, Switzerland, the company aims to combat antibiotic resistance, which is projected to cause 10 million deaths annually by 2050. Clemedi's test kits are designed to diagnose drug-resistant infections directly from patient samples within a day, thereby enhancing doctors' decision-making and facilitating timely, personalized antibiotic therapies. By providing comprehensive information for targeted treatment, Clemedi strives to reduce antibiotic consumption and slow the spread of resistance, ultimately benefiting patients suffering from infectious diseases.

Watttron GmbH, founded in 2016 and based in Freital, Germany, specializes in the development of innovative heating systems that ensure precise temperature control and efficient energy management across various industrial applications. The company offers a range of products, including matrix heating and sealing heat systems, as well as customized heating solutions and simulation services. Watttron's advanced technology enables heterogeneous heating of surfaces, making it superior to traditional heating methods. Its systems are utilized in diverse sectors such as polymer processing, packaging, additive manufacturing, chemistry, microelectronics, biotechnology, automotive, and medicine, allowing for the effective processing of bio-based and recycled materials.

Hempfy is a Swiss company specializing in the production of innovative, THC-free hemp-infused food and beverages. Utilizing proprietary cold infusion technology, Hempfy cultivates, harvests, and processes hemp plants in compliance with Swiss legislation. All products are 100% Swiss-made, with a focus on bespoke quality, from seed selection to final production. Hempfy aims to replace smoking and alcohol as the world's preferred social drug, offering cannabis-based products with a balanced taste and light carbonation.

OxyPrem AG is a Swiss company that specializes in developing and manufacturing sensor solutions for monitoring preterm infants. Founded in 2018 and based in Zurich, OxyPrem offers an advanced reusable oxygen sensor that continuously measures brain oxygen levels in high-risk preterm infants using noninvasive near-infrared light technology. This device accurately determines hemoglobin oxygen saturation in any human tissue, allowing healthcare providers to deliver improved clinical care while significantly reducing waste. By enabling real-time monitoring, OxyPrem's technology plays a crucial role in preventing early death and mitigating the risk of severe long-term brain damage in this vulnerable population.

iWin, based in Manno, Switzerland, specializes in the development of an innovative photovoltaic venetian-blind shading device that is seamlessly integrated into insulating windows without affecting their design or functionality. Established in 2019, the company aims to enhance building sustainability, as the construction sector is responsible for approximately 40% of global CO2 emissions. The patented system not only generates renewable energy on-site but also effectively controls light and solar radiation, protecting buildings from overheating in summer. iWin’s product is customizable in size and color, durable, and requires minimal maintenance, boasting a payback period of less than ten years. The company has created its first working prototype and has formed partnerships with SUPSI and Pellini Group, a leader in integral venetian blinds. With a significant market opportunity, particularly in Switzerland where around 900,000 square meters of glass façades are installed annually, iWin is poised for growth in the sustainable building sector.

Microcaps AG is a company based in Zurich, Switzerland, specializing in the development of innovative microencapsulation technology. Founded in 2018, it focuses on creating a scalable production system for precise microcapsules and microparticles using advanced microfluidics. The company's devices enable the fabrication of monodisperse capsules and emulsions of various sizes, providing tailored solutions for drug delivery, probiotic encapsulation, and enhancing the stability of pharmaceutical agents and fragrances in cosmetic products. Microcaps aims to offer a fully automated encapsulation micro-factory that ensures size control and precise dosing, significantly improving production efficiency and throughput rates compared to conventional methods.

Authena is a traceability solution provider headquartered in Zug, Switzerland, specializing in enhancing transparency across the supply chain through the integration of IoT devices, blockchain, and AI technologies. Its platform offers real-time, unit-level tracking and environmental condition monitoring, enabling industries such as Pharmaceuticals, Luxury, and Food and Beverage to safeguard brand reputation and consumer trust. Authena's notable products, Authena SHIELD™ and Authena L1VE, not only comply with regulatory standards but also foster consumer confidence through transparency and authenticity. The company is recognized for its commitment to sustainability and is the only traceability solution provider incorporated into NEOM's Oxagon accelerator, positioning itself as a leader in promoting a greener future. By protecting product identity against counterfeiting, diversion, and fraud, Authena helps brands achieve full visibility, improve financial performance, and enhance direct-to-consumer sales.

Biospectal is a company focused on remote patient monitoring and biosensing, having developed the OptiBP smartphone app and data platform for blood pressure measurement. This innovative app allows users to measure their blood pressure using the built-in camera of a smartphone, capturing blood flow through the fingertip in a quick and easy manner. The measurement process takes approximately 20 seconds, which is significantly faster than traditional blood pressure cuffs. Biospectal’s proprietary algorithms analyze the optical signals captured by the camera to provide accurate blood pressure readings. Currently, the public beta of the OptiBP app for Android is available in several countries, including the United States, the United Kingdom, France, Germany, Spain, and Switzerland. This technology empowers individuals to monitor their blood pressure anytime and anywhere, transforming smartphones into medical-grade devices without the need for additional peripherals.

Prodibi is a professional image platform that enhances the online display of images to boost brand ROI, improve user engagement, and streamline the work of developers. Launched in 2011 and based in Geneva, Switzerland, the platform addresses common challenges in image quality, performance, color management, pixel density, responsiveness, and SEO, which can be costly and time-consuming to resolve. For example, tasks like cropping images can take significant time for graphic designers. Prodibi simplifies this process by allowing users to replace online images with a single click, ensuring an exceptional visual experience that aligns with brand prestige. The subscription-based service enables photographers, professional artists, and web publishers to showcase their work effectively on both web and mobile platforms without sacrificing speed or quality.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.

BASF, established in 1865, is the world's largest chemical company, operating globally with a top-three market position in approximately 70% of its businesses. Its portfolio spans the full chemical spectrum, from commodities to specialties, including agricultural chemicals and emissions control catalysts. BASF Venture Capital, founded in 2001, is the company's corporate venture capital arm. It invests worldwide in promising startups and funds relevant to BASF's current and future business fields, focusing on innovations in chemistry, new materials, sustainability, digitization, and new business models. The firm supports its portfolio companies by leveraging BASF's global research, partnership, and customer networks. BASF Venture Capital is headquartered in Ludwigshafen, Germany, with additional offices in San Francisco, Boston, Shanghai, Sao Paulo, and Tel Aviv.

Securaxis specializes in the development, installation, and operation of innovative safety and security solutions. Founded in 2018 as the first incubated company of BIC of CERN Technologies in Switzerland, Securaxis has garnered recognition through various accolades, including the Entreprendre Network and Swisscom Start-up Challenge. The company is part of the HP Enterprise Startup Incubator and the NVIDIA Inception Program. Securaxis has a dedicated team of eight experts in fields such as machine learning, acoustics, and data management, who have collaborated for over four years. They have successfully developed and commercialized a mobile security application utilized by clients including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations. Securaxis operates a real-time geolocalized security information platform that employs smart acoustic sensors to analyze and classify sounds in urban environments, enabling organizations to make informed decisions to enhance safety.

Akselos S.A. is a Switzerland-based company that develops Integra, a cloud-based engineering simulation software designed for asset-centric industries such as oil and gas and offshore wind. Founded in 2011, Akselos enables engineers to create high-resolution simulations of large-scale operational assets through its advanced digital twin technology. The Integra platform allows users to build detailed 3D models, adjust various parameters, perform hydrodynamic analysis, and evaluate the structural integrity of fixed offshore assets and other critical infrastructure. With patented algorithms that enhance simulation speed and accuracy, Akselos aims to support preventative maintenance and reduce unplanned downtime by providing real-time insights into asset conditions. The company operates in various regions, including Europe, the USA, and Southeast Asia, and maintains a subsidiary in Cambridge, Massachusetts.

ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

Nagi Bioscience SA, based in Lausanne, Switzerland, specializes in the development and manufacturing of an innovative automated testing device that utilizes microscopic worms for substance testing in pharmaceutical, chemical, and cosmetic industries. Their flagship product, the Caenorhabditis elegans-on-chip, integrates the use of these organisms for in vivo testing with a fully automated platform for in vitro culture, treatment, and analysis. This technology facilitates comprehensive toxicity testing, drug discovery, and anthelmintic testing applications, allowing clients to evaluate biological responses observable only at the whole-organism level. Nagi Bioscience aims to transform traditional testing methodologies by introducing its unique "Organism-on-Chip" technology.

Bloom Biorenewables Ltd is a Swiss company founded in 2019, focused on developing technology that transforms wood and agricultural waste into renewable materials as alternatives to petroleum. The company specializes in creating bio-based materials for the chemical industry, targeting various markets including fragrances, plastics, and textiles. By introducing innovative production methods for biorenewable products and fuels, Bloom Biorenewables aims to provide sustainable solutions that reduce reliance on fossil fuels and contribute to climate change mitigation.

Lab-on-Fiber GmbH, based in Halle, Germany, specializes in the development and production of advanced medical laser probes and systems aimed at enhancing minimally invasive surgical procedures. The company offers a range of fiber delivery systems, including surgical and urology fiber probes. By providing optimized radiation profiles and real-time temperature monitoring at the probe surface, Lab-on-Fiber's technology helps surgeons reduce operating times, improve treatment outcomes, and enhance patient safety. Their innovative solutions are designed to streamline laser surgery while minimizing potential complications, positioning Lab-on-Fiber as a key player in the medical technology sector.

Aspivix SA is a Swiss company specializing in the development of innovative medical devices aimed at enhancing gynecological procedures. Founded in 2015 and headquartered in Lausanne, Aspivix focuses on creating minimally invasive surgical instruments that prioritize patient comfort and safety. Its flagship product, CAREVIX, utilizes a patented suction technology to stabilize the cervix during procedures, effectively reducing pain and minimizing the risk of bleeding, lesions, and infections. This approach replaces traditional methods, such as the use of forceps, offering a gentler alternative for both women and gynecologists. Through its advancements, Aspivix aims to transform the landscape of gynecological care by making procedures safer and more efficient.

Kejako SA is a Swiss company specializing in the research and development of medical devices for the ophthalmic surgery sector, specifically targeting presbyopia. Founded in 2015 and headquartered in Plan-les-Ouates, Switzerland, Kejako aims to provide a non-invasive solution for patients experiencing a decline in visual accommodation due to age-related changes. The company employs a unique approach that combines simulation with minimally invasive treatments, utilizing a full eye 3D parametric model alongside multi-physics numerical modeling to assess the eye's optical and mechanical behavior. This innovation enables patients to better plan and control their customized procedures, ultimately enhancing their quality of life as they manage the effects of presbyopia.

ALAnostics is a biopharmaceutical company that specializes in oncodiagnostics, originating as a spin-off from the University of Geneva. The company focuses on developing innovative tumour painting technology designed to assist surgeons in the real-time identification and removal of breast cancer during surgery. By utilizing nanomedicines for fluorescence-guided surgery, along with 5-ALA prodrugs for photodynamic therapy and light-activated antimicrobials, ALAnostics aims to enhance the accuracy of tumor removal, ultimately improving patient outcomes and saving lives.

Rapid Graft is a medical device company founded in 2018 and based in Zurich, Switzerland. The company specializes in developing an innovative dermatome designed to facilitate the precise and rapid harvesting of small split-skin grafts. This technology aims to enhance the treatment of chronic wound patients and address future needs in tissue engineering. The device enables surgeons to perform skin grafting procedures with minimal discomfort, eliminating the need for specialist intervention or an operating room. Additionally, it reduces the risk of infection and scarring, promoting faster skin cell regeneration and improved healing outcomes for patients.

Flyla GmbH, founded in 2018 and based in Munich, Germany, specializes in online booking solutions tailored for students and young travelers. The company connects with airlines to establish student fares as part of a revenue management strategy, distributing these discounted rates to its growing network of enrolled university students. By offering an intuitive online platform, Flyla simplifies travel arrangements, allowing users to easily access deals, provide necessary travel details, and complete payments. This approach aims to address the financial barriers faced by students, making air travel more accessible and affordable.

Aesyra SA, founded in 2017 and based in Lausanne, Switzerland, specializes in the design and manufacture of medical devices focused on managing sleep disorders. The company's flagship product, AesyBite, is an intra-oral sensor that monitors and alleviates sleep bruxism, a condition characterized by teeth grinding during sleep. Aesyra's technology enables dental professionals to conduct intraoral measurements while patients sleep, allowing for the detection of bruxism and other sleep-related issues, such as obstructive sleep apnea. By providing accurate monitoring and biofeedback alternatives, Aesyra aims to help healthcare providers reduce damage to dental prostheses caused by occlusal problems and improve overall sleep quality for their patients.

Parquery AG, founded in 2014 and based in Zurich, Switzerland, specializes in smart parking solutions through the development of a web application that provides real-time on-street parking availability. The company employs computer vision and machine learning technologies to analyze images and detect parking vacancies, utilizing snapshots from existing cameras to deliver accurate data. This service caters to parking managers and supports smart city and mobility initiatives by offering insights into past, current, and predicted future usage of parking facilities, thereby facilitating smarter routing options for drivers seeking available parking spots.

Letos is a computer software startup founded in 2016 and headquartered in Brandenburg, Germany. The company specializes in behavioral sciences, affective neuroscience, and well-being technologies. Letos develops machine learning technology that predicts user behavioral reactions by utilizing biosensors and advanced machine learning techniques. This platform captures genuine spontaneous emotional responses, allowing organizations to assess user satisfaction, alertness, and overall well-being while ensuring user anonymity. By placing the human user at the center of its innovations, Letos aims to enhance the understanding of user experiences in various applications.

Nanogence SA, established in 2017 and located in Renens, Switzerland, specializes in the development of innovative material solutions for the construction industry. The company focuses on creating synthetic, tailor-made materials that enhance the performance and sustainability of construction applications, including cement and concrete. By leveraging advanced knowledge in chemistry, material science, and nanotechnology, Nanogence has developed patented additive formulations that significantly improve the binding efficiency of cement and concrete while reducing carbon emissions by up to 50%. This enables manufacturers to achieve valuable cost savings, enhance durability, and contribute to more sustainable construction practices in a rapidly growing global market.

Lymphatica Medtech SA is a Swiss company focused on designing and manufacturing medical devices for the treatment of lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed LymphoDrain, an innovative medical device that aims to re-establish lymphatic circulation. This system includes an active implantable lymphatic bypass, featuring a magnetically controlled micropump and subcutaneous catheters that facilitate the internal drainage of lymphatic fluid from multiple points within the affected limb. Lymphatica Medtech also produces essential components for LymphoDrain, such as the micropump head and wearable controller, providing a minimally invasive solution for individuals suffering from persistent lymphedema.

Alogo Analysis SA, based in Apples, Switzerland, specializes in developing advanced analytics tools for the equine industry, particularly focusing on equestrian sports like show-jumping. Founded in 2016, the company aims to modernize the discipline by providing innovative solutions that quantify athlete performance. Its flagship product, Move, allows users to assess horse performance and monitor health and locomotion through a web application that displays comprehensive data. By offering novel performance statistics, Alogo Analysis SA seeks to enhance understanding of equestrian sports, improve spectator experience, and increase fan engagement, thus contributing to the evolution of the sport at both training and competition levels.

LEDsafari SA, founded in 2014 and based in Lausanne, Switzerland, focuses on sustainability education through innovative training programs and solar kits. The company aims to empower future generations to address climate change by providing hands-on learning experiences in schools and educational institutions. Its flagship product is a solar kit that enables users to assemble an electrical circuit and create a lamp from recycled materials. This approach not only teaches solar technology theories but also promotes eco-friendly practices. LEDsafari has successfully sold 15,000 solar kits across 15 countries via its online platform. The company is also developing a state-of-the-art learning platform featuring high-quality animations, graphics, and games, with plans to incorporate augmented reality and mobile technology in the future.

Social Fabric is a sustainable textile center that promotes the use of environmentally friendly and socially responsible textiles. The organization aims to combine a circular economy with innovative technology and decentralized manufacturing to provide customers with customized garments. It operates as a community-based association, focusing on two main areas: integrating refugees into the workforce in Switzerland and enhancing sustainability in textile production. By prioritizing ethical labor practices and minimizing ecological impact, Social Fabric offers individuals access to meaningful and sustainable textile products.

BAABUK is a Swiss company founded in 2013 by a dynamic couple, Galina and Dan. Their story began when Galina's parents gave Dan a pair of traditional Russian "Valenkis". In the past, these Russian felted boots were essential to fight the Siberian cold. So after trying them out in the snow, Galina and Dan had an idea! Why not preserve the "Valenki" ancestral know-how and create a revised pair of 100% wool shoes? That's when the first BAABUK pair of shoes was born, and they didn't stop there...

TWIICE is a Swiss company established in 2015 that specializes in the development and manufacturing of lower limb exoskeletons tailored for individuals with mobility impairments, particularly paraplegics. The exoskeletons are designed to assist users in standing and walking, incorporating electric motors that facilitate movement in the hip and knee joints. By offering customer-specific solutions that adapt to various morphologies and pathologies, TWIICE aims to restore the sensations and benefits associated with ambulation, thereby promoting greater independence in daily activities for individuals facing mobility challenges.

Skypull SA is a Swiss company founded in 2013, focused on developing an airborne wind energy system that utilizes a hybrid drone capable of vertical take-off and landing. This drone operates at higher altitudes, where it captures energy from strong and consistent winds through a tether connected to a ground-based generator, thereby generating electricity. Skypull's proprietary airframe design enhances the drone's efficiency and versatility, setting it apart from competitors. The company's technology aims to provide an affordable and clean energy solution that contributes to climate change mitigation by facilitating the transition from fossil fuels to renewable energy sources.

GliaPharm SA is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders. Founded in 2016 and based in Geneva, the company utilizes its GliaX technology platform to identify drugs that target the activity of glial cells, which are essential support cells for neurons. This innovative approach aims to enhance brain metabolism in pathological conditions. GliaPharm employs high throughput screening technologies and conducts metabolic tests on both in vitro primary brain cell cultures and in vivo rodent models to evaluate compounds. The company addresses various neurological conditions, including Alzheimer's disease and amyotrophic lateral sclerosis (ALS), and collaborates with contract research organizations to advance its drug development and regulatory processes. With a vision to lead in glia-mediated therapies, GliaPharm seeks to provide new neuroprotective agents that support cognitive function in patients.

MagicTomato operates an online grocery marketplace that focuses on providing locally made and sourced products. Founded in September 2016 in the Geneva area, the company aims to encourage consumers to adopt healthier grocery shopping habits by offering a selection of over 800 non-industrial and GMO-free items. Their product range includes fresh fruits, vegetables, meats, fish, dairy, organic flours, and various beverages, all sourced from a network of 30 local artisans. MagicTomato emphasizes sustainability through a decentralized business model, aiming to eliminate food waste and packaging while ensuring ultimate freshness. They offer same-day delivery, making it convenient for consumers to access high-quality products from independent craftsmen in their region. The company is already at breakeven, reflecting its successful implementation of this innovative grocery approach.

ChemAlive SA is a company based in Lausanne, Switzerland, that specializes in developing an online computational chemistry platform. This platform provides accurate analytics for various chemical sectors by utilizing managed cloud computing, automation algorithms, and a comprehensive database. ChemAlive's technology allows chemists to automatically calculate quantum data related to molecular properties and synthetic reactions, starting from standard 2D chemical input. By offering a user-friendly environment, the platform caters to both experts and non-experts in fields such as academic research, pharmaceuticals, and contract research. Founded in 2014, ChemAlive is transitioning from a consultancy model to integrating machine learning and big data techniques, significantly reducing the time required to obtain precise information from days to minutes. This innovative approach aims to enhance the design and understanding of chemical processes, ultimately streamlining research and development efforts and improving market readiness.

MEMBRASENZ GmbH was founded in June 2015 by Dr. Jelena Stojadinovic and Prof. Dr. Fabio La Mantia. The company's mission is to supply innovative gas separator solutions for electrolyzers’ industry and make hydrogen universally accessible. Moreover, MEMBRASENZ’s vision is to be the supplier of resource supporting products enabling the sustainability of sense and integrity based energy systems. The company is a spin-off of the Center for Electrochemical Sciences at the Ruhr-University Bochum. MEMBRASENZ has been supported by German Ministry of Economy and Energy BMWi (EXIST grant), Cluster of Excellence RESOLV "Ruhr Explores Solvation" and Horizon 2020 EU Framework Programme for Research and Innovation.

GuestLee is a Swiss Property Management company. In a exponentially growing market GuestLee positioning settled naturally by trust & recommendation to high-end property owners. 90% of their customers are seniors that worked hard to build real estate assets. With today’s versatile economical environment, living on savings or limited pension allowances, it is quite difficult to sustain life standards as well as to pay property maintenance fees. GuestLee is a decentralized business model using latest technologies to help seniors to generate revenue

RiskTalk Ltd is a developer of a communication tool aimed at enhancing employee engagement regarding issues that impact core organizational values. Founded in 2016 and headquartered in Lausanne, Switzerland, with an additional office in Kent, United Kingdom, RiskTalk enables a bottom-up communication approach, allowing employees to report concerns without fear of bias or reprisal. The tool facilitates the identification and logging of risks, turning discussions into actionable items by assigning responsibilities to appropriate personnel and providing feedback mechanisms. This innovative approach aims to create a blame-free environment for addressing risks, thereby improving overall organizational responsiveness and accountability.

Imverse is a 3D graphics software company headquartered in Plan-les-Ouates, Geneva, specializing in volumetric technology for location-based entertainment and enterprise applications. Founded in 2017, the company provides real-time simulation and modeling tools that transform 2D images into immersive 3D virtual environments suitable for live streaming, gaming, and remote collaboration. Its platform leverages depth cameras and reality capture software to enable the streaming of real-time three-dimensional holograms, fostering deeper personal connections and enhancing communication and content creation for various organizations. As a subsidiary of Imverse SA, Imverse aims to innovate the way users engage with digital content through advanced volumetric video solutions.

Sleepiz AG, based in Zurich, Switzerland, specializes in manufacturing a non-contact sleep monitoring device aimed at enhancing healthcare accessibility in home environments. Incorporated in 2018, the company's innovative product is designed to be placed on a bedside table, where it accurately measures patients' breathing patterns, heart rate, and body movements using advanced wireless millimeter wave technology and artificial intelligence. This device not only facilitates the diagnosis of sleep disorders but also enables long-term monitoring of chronic diseases, allowing healthcare providers to track patient progression and implement timely interventions for improved treatment outcomes. Through its user-friendly and precise approach, Sleepiz is positioned to significantly contribute to patient-centric disease management.

Inflight VR Software GmbH, founded in 2014 and based in Munich, Germany, specializes in developing virtual reality ecosystems tailored for the inflight entertainment sector. In the aftermath of the COVID-19 pandemic, airlines are actively seeking innovative revenue streams to enhance passenger satisfaction. The Inflight VR entertainment system enables airlines to monetize their services through pay-per-view, advertising, and e-commerce, while providing an immersive experience that captures passengers' attention. The technology has been successfully implemented by prominent clients such as Qatar Airways and Singapore Airlines, demonstrating strong demand within the travel industry. It boasts impressive engagement metrics, with passengers averaging over 80 minutes of usage and a satisfaction rate exceeding 90%. Each passenger utilizing Inflight VR contributes a revenue potential of more than €7, highlighting its effectiveness in addressing the evolving needs of the airline industry.

TieTalent is a tech-focused job platform based in Switzerland that connects companies with highly qualified talents in IT and digital marketing. Utilizing a combination of artificial intelligence and user psychometric data analysis, along with human expertise, TieTalent streamlines the recruitment process. The platform enhances the quality of hires for employers while reducing the time and costs associated with traditional hiring methods. It emphasizes a candidate-centric approach, eliminating the need for motivation letters, job applications, and unsolicited recruitment calls, thereby transforming the recruitment experience into a more straightforward and engaging process.

Inflight VR Software GmbH, founded in 2014 and based in Munich, Germany, specializes in developing virtual reality ecosystems tailored for the inflight entertainment sector. In the aftermath of the COVID-19 pandemic, airlines are actively seeking innovative revenue streams to enhance passenger satisfaction. The Inflight VR entertainment system enables airlines to monetize their services through pay-per-view, advertising, and e-commerce, while providing an immersive experience that captures passengers' attention. The technology has been successfully implemented by prominent clients such as Qatar Airways and Singapore Airlines, demonstrating strong demand within the travel industry. It boasts impressive engagement metrics, with passengers averaging over 80 minutes of usage and a satisfaction rate exceeding 90%. Each passenger utilizing Inflight VR contributes a revenue potential of more than €7, highlighting its effectiveness in addressing the evolving needs of the airline industry.

Securaxis specializes in the development, installation, and operation of innovative safety and security solutions. Founded in 2018 as the first incubated company of BIC of CERN Technologies in Switzerland, Securaxis has garnered recognition through various accolades, including the Entreprendre Network and Swisscom Start-up Challenge. The company is part of the HP Enterprise Startup Incubator and the NVIDIA Inception Program. Securaxis has a dedicated team of eight experts in fields such as machine learning, acoustics, and data management, who have collaborated for over four years. They have successfully developed and commercialized a mobile security application utilized by clients including the Federal Department of Foreign Affairs in Switzerland, the Olympic Committee, and the United Nations. Securaxis operates a real-time geolocalized security information platform that employs smart acoustic sensors to analyze and classify sounds in urban environments, enabling organizations to make informed decisions to enhance safety.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

Artmyn SA specializes in the digitization of visual artworks, offering a comprehensive platform that allows users to access high-quality digital representations of art through web browsers on various devices, including laptops, smartphones, and tablets. Founded in 2015 and based in Belmont-sur-Lausanne, Switzerland, the company utilizes a portable scanner to capture extensive data about artworks, ensuring accurate and detailed visualizations. Artmyn provides an array of services such as online galleries, interactive guided tours, educational resources, and conservation monitoring tools, catering to museums, galleries, auction houses, and both private and institutional collectors. By enhancing the art viewing experience, Artmyn facilitates greater transparency and engagement for art buyers and enthusiasts alike.

Fastree3D is a fabless semiconductor company based in Switzerland, specializing in the development of three-dimensional imaging sensors that facilitate real-time recognition and distance measurement of fast-moving objects. Founded in September 2013 as a spin-off from EPFL Lausanne, Fastree3D aims to enhance driving assistance and autonomous navigation systems. The company's sensors utilize complementary metal-oxide-semiconductor (CMOS) technology, enabling precise detection and localization of objects in three dimensions. Through its subsidiary, Fastree3D B.V., the company collaborates with TU-Delft in the Netherlands to advance research and innovation in this field, ultimately supporting clients in creating vehicles and machines capable of continuously monitoring their environment.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, the company is dedicated to addressing the unmet medical needs of patients globally. Its lead candidate, VS-01, is in the preclinical stage and aims to be the first drug for acute liver disease, with the unique capability of supporting multiple organ function. VS-01 has received Orphan Drug Designation for acute liver failure, highlighting its potential in treating rare conditions. Additionally, Versantis is advancing other products in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent significant opportunities for improving patient outcomes in the field of liver health and beyond.

SwissDeCode is a company based in Renens, Switzerland, that specializes in food safety and compliance services for food manufacturers. Founded in 2016, the company provides rapid onsite DNA testing solutions that help ensure food is safe to eat. By offering plug-and-play systems, SwissDeCode enables production facilities to obtain food safety and quality certificates within the same work shift. This capability allows food producers to swiftly address contamination threats and convert them into sustainable opportunities. Additionally, SwissDeCode's services verify food authenticity, safety, and origin, empowering inspectors to make immediate decisions regarding food compliance.

TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements designed for sustainable animal farming. Founded in 2015 and based in Root, Switzerland, the company has developed a triple active probiotic that addresses key challenges in intensive animal farming, such as improving digestion, enhancing responses to plant-based feeds, and promoting better feed conversion ratios. This innovative product, rooted in research on intestinal health from the École Polytechnique Fédérale de Lausanne (EPFL), aims to optimize gut microbiota, which is vital for food metabolism and immune defense. By offering significant benefits, such as reduced disease incidence and lower ecological impact, TwentyGreen seeks to capture a 10% share of the rapidly growing global animal feed probiotic market, valued at over $4 billion annually. To achieve this, the company engages in extensive research and development in collaboration with academic partners, ensuring compliance with regulatory standards for both human food and animal feed.

Includeed is a consultancy and innovative solution provider focused on promoting diversity and inclusion, particularly in relation to gender issues. Founded in 2015 and based in Les Acacias, Switzerland, the company operates a platform that allows employees, job seekers, and customers to review and share experiences, ask questions, suggest solutions, and request companies to disclose information regarding diversity and equal opportunities. Includeed's programs extend across several locations, including Geneva, Zurich, Paris, and Lyon, aiming to foster dialogue and transparency in workplace practices related to diversity.

Smart Home Technology GmbH, founded in 2014 and based in Zurich, Switzerland, specializes in the development of smart home devices and home automation products. The company is committed to enhancing existing systems through innovative solutions that prioritize ultra-low power consumption and reliability. Utilizing zero-standby power technology, Smart Home Technology enables the operation of electrical devices with minimal energy loss. Their approach encompasses a comprehensive understanding of security and communication concepts, delivering highly efficient systems paired with advanced software tailored for business clients in the cleantech and smart home sectors.

Eyeware Tech SA, founded in 2016 and based in Martigny, Switzerland, specializes in developing advanced eye and head tracking software, known as GazeSense, which utilizes consumer cameras. This innovative technology is applicable across a variety of sectors, including social robotics, automotive, healthcare, gaming, and advertising. As a research spin-off from EPFL and the Idiap Research Institute, Eyeware focuses on creating platform-independent solutions that leverage proprietary computer vision algorithms and machine perception AI. These advancements enable cost-effective and reliable eye tracking without the need for specialized hardware. Eyeware's software allows devices to understand user attention and intention, facilitating more natural interactions between people and technology. The company’s offerings are designed to support a wide range of applications, positioning Eyeware as a key player in the integration of human perception technology into everyday consumer devices and services.

Planet Hort - learning sustainability in a playful way“ is the first organization in Switzerland that aims to integrate Education for Sustainable Development into after-school care. Their activities and courses deal with the five main sustainability topics biodiversity, cultural plurality, consumption, energy and waste. With their program they want to encourage children at an early stage to engage in a sustainable interaction with the environment. And empower day-care personal to adopt their approach. Planet Hort - learning sustainability in a playful way“ wants to integrate Education for Sustainable Development into after-school care.

Gait Up SA, founded in 2013 and based in Lausanne, Switzerland, specializes in the manufacturing of motion analytics wearables used in smartwatches and other hardware. As a spin-off from the University Hospital of Lausanne and the Swiss Institute of Technology, the company leverages over 15 years of scientific expertise in movement analysis and measurement. Gait Up offers innovative products that enable objective evaluation of health and performance through advanced wearable sensor technology. The company has established a strong reputation, serving more than 50 clients across academia, clinics, and various industries in Europe, Canada, the United States, and Asia. In 2017, Gait Up became a subsidiary of MindMaze SA.

CyanoGuard AG is a Swiss chemical technology company established in 2016, focused on advancing methods for cyanide detection across various sectors, including mining, environmental monitoring, food safety, and healthcare. The company specializes in providing innovative solutions such as CyanoKit, a semi-quantitative cyanide test, and CyanoGuard, a mobile quantitative monitoring test. Additionally, it offers Cyano.iO, an online monitoring and optimization platform. CyanoGuard's technology is designed to deliver fast and safe cyanide detection in diverse samples, requiring no specialized training or equipment. With over six years of collaboration with industry partners, the company aims to address cyanide-related challenges effectively, ensuring reliable monitoring and compliance in different settings.

Fastree3D is a fabless semiconductor company based in Switzerland, specializing in the development of three-dimensional imaging sensors that facilitate real-time recognition and distance measurement of fast-moving objects. Founded in September 2013 as a spin-off from EPFL Lausanne, Fastree3D aims to enhance driving assistance and autonomous navigation systems. The company's sensors utilize complementary metal-oxide-semiconductor (CMOS) technology, enabling precise detection and localization of objects in three dimensions. Through its subsidiary, Fastree3D B.V., the company collaborates with TU-Delft in the Netherlands to advance research and innovation in this field, ultimately supporting clients in creating vehicles and machines capable of continuously monitoring their environment.

Artmyn SA specializes in the digitization of visual artworks, offering a comprehensive platform that allows users to access high-quality digital representations of art through web browsers on various devices, including laptops, smartphones, and tablets. Founded in 2015 and based in Belmont-sur-Lausanne, Switzerland, the company utilizes a portable scanner to capture extensive data about artworks, ensuring accurate and detailed visualizations. Artmyn provides an array of services such as online galleries, interactive guided tours, educational resources, and conservation monitoring tools, catering to museums, galleries, auction houses, and both private and institutional collectors. By enhancing the art viewing experience, Artmyn facilitates greater transparency and engagement for art buyers and enthusiasts alike.

Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.

Rayform SA specializes in innovative light redirection technology that enhances design possibilities for luxury products and packaging. Founded in 2016 and based in Ecublens, Switzerland, the company employs a proprietary computer algorithm to calculate the three-dimensional surfaces necessary for producing specific light images. By modifying the shape of transparent or reflective surfaces according to the algorithm's output, Rayform redirects incoming light to create clear and intricate images on adjacent surfaces. This technology not only allows for unique artistic and design applications but also serves as a tool for brands to create memorable consumer experiences and combat counterfeiting.

Rqmicro is a Swiss company based in Zurich that specializes in pathogen separation and detection technology. Founded in 2013, it focuses on providing rapid microbial assessments for water and food safety. The company has developed proprietary reagents and instruments that deliver accurate results in less than one hour, allowing for quick detection of dangerous water and foodborne pathogens. This technology enables clients to obtain quantitative data on contamination levels, thereby enhancing overall safety in food and water supplies.

MagnebotiX, established in 2014 and based in Zurich, specializes in the development and manufacturing of magnetic manipulation systems. The company focuses on creating magnetic field generators and micromagnetic agents that facilitate both fundamental and applied research in science and engineering. Their innovative products utilize magnetic fields to enable wireless micromanipulation, making it possible to perform tasks in challenging environments. This includes the use of their systems as untethered mechanical probes for accessing hard-to-reach locations and for delivering targeted cargo in minimally invasive biological studies. MagnebotiX aims to advance research on magnetic phenomena and develop applications for magnetic microrobots, thereby enhancing capabilities in various research fields.

Pingen is an online solution to send documents by letter post for private, business, and software integration. Users can either upload PDFs from their desktops or fetch files online from their Dropbox, Google Drive, and Microsoft Skydrive accounts. Pingen was launched in 2010 and is operated from Zürich, Switzerland.

incredX AG, founded in 2011 by a team of former AO Foundation executives and surgeons, is a Swiss-based company focused on enhancing global healthcare systems through modern technology. The company has developed a cloud-based platform that facilitates the recording, tracking, and sharing of Patient Outcome Measures. This innovative system serves as a collaborative tool for medical professionals and patients, allowing them to exchange treatment and outcome data effectively. By enabling healthcare providers to quickly identify and adopt proven best practices, incredX aims to improve patient care and enhance the overall quality of healthcare services.

Biowatch SA, founded in 2015 and headquartered in Martigny, Switzerland, has developed a biometric identification system that integrates into the buckle of a watchband, allowing for secure authentication through the unique patterns of veins on a user's wrist. The Biowatch functions as a user-friendly biometric reader, providing a security solution for mobile payments and smart device interactions. Users can enroll their vein patterns via an application, which enables them to connect their Biowatch to various devices and applications. Once enrolled, users can authenticate themselves by matching their vein patterns, allowing them to access services and premises without the need for traditional keys, passwords, or PIN codes. The technology aims to simplify and enhance security measures in everyday transactions and interactions.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Akselos S.A. is a Switzerland-based company that develops Integra, a cloud-based engineering simulation software designed for asset-centric industries such as oil and gas and offshore wind. Founded in 2011, Akselos enables engineers to create high-resolution simulations of large-scale operational assets through its advanced digital twin technology. The Integra platform allows users to build detailed 3D models, adjust various parameters, perform hydrodynamic analysis, and evaluate the structural integrity of fixed offshore assets and other critical infrastructure. With patented algorithms that enhance simulation speed and accuracy, Akselos aims to support preventative maintenance and reduce unplanned downtime by providing real-time insights into asset conditions. The company operates in various regions, including Europe, the USA, and Southeast Asia, and maintains a subsidiary in Cambridge, Massachusetts.